Adventa Bhd (XKLS:7191) 3-Year RORE % : 107.06% (As of Mar. 2026)


XKLS:7191 Adventa Bhd XKLS:7191
29 GF Score
Price RM0.13
GF Value RM0.24
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Adventa Bhd 3-Year RORE %?

Adventa Bhd XKLS:7191 29 3-Year RORE % is 107.06 as of Mar. 2026. GuruFocus rates XKLS:7191 with a GF Score™ of 29/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 777 Medical Devices & Instruments companies, Adventa Bhd ranks better than 91.89% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Adventa Bhd's 3-Year RORE % for the quarter that ended in Mar. 2026 was 107.06%.

The industry rank for Adventa Bhd's 3-Year RORE % or its related term are showing as below:

XKLS:7191's 3-Year RORE % is ranked better than
91.89% of 777 companies
in the Medical Devices & Instruments industry
Industry Median: -4.03 vs XKLS:7191: 107.06

Adventa Bhd  (XKLS:7191) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Adventa Bhd 3-Year RORE % Related Terms


Adventa Bhd 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Adventa Bhd's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adventa Bhd 3-Year RORE % Chart

Adventa Bhd Annual Data
Trend Oct15 Oct16 Oct17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.10 -171.43 -1,362.50 -62.07 225.00

Adventa Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 373.68 389.74 296.08 225.00 107.06

XKLS:7191 vs ISRG, BDX, MDLN: 3-Year RORE % Comparison

For the Medical Instruments & Supplies subindustry, Adventa Bhd's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adventa Bhd 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's 3-Year RORE % falls into.


XKLS:7191
29GF Score
Adventa Bhd XKLS:7191
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adventa Bhd 3-Year RORE % Calculation

Adventa Bhd's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.669--0.032 )/( -0.595-0 )
=-0.637/-0.595
=107.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 107.06 mean?
Adventa Bhd (XKLS:7191) has a 3-Year RORE % of 107.06 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Adventa Bhd and its competitors. According to the industry distribution chart, Adventa Bhd ranks #63 out of 777 companies in the Medical Devices & Instruments industry, placing it in the top 8.1%.
Is Adventa Bhd's 3-Year RORE % too high?
Adventa Bhd's current 3-Year RORE % is 107.06. Based on the distribution chart, Adventa Bhd ranks #63 out of 777 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Adventa Bhd has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's 3-Year RORE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #63 out of 777 companies for 3-Year RORE %. This places Adventa Bhd in the top 8% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Adventa Bhd and its competitors. Adventa Bhd's current 3-Year RORE % is 107.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 47.9% below its estimated fair value. The current 3-Year RORE % is 107.06. Adventa Bhd's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current 3-Year RORE % is 107.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adventa Bhd (XKLS:7191) Overvalued in 2026?

Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued. The current stock price of RM0.13 is trading 47.9% below its estimated GF Value™ of RM0.24. GuruFocus considers Adventa Bhd to be Possible Value Trap.

Key valuation signals for XKLS:7191:

  • 3-Year RORE %: 107.06
  • GF Value™: RM0.24 vs. price of RM0.13 (47.9% below fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adventa Bhd Business Description

Address No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
29GF Score

Get the complete analysis for XKLS:7191

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.13
Price
RM0.24
GF Value